WHIPgroup Successfully Invalidates Medical Device Patent In PTAB Inter Partes Review Proceeding

March, 16th, 2017

Categories: Articles, Blog, News Tags: patent, PTAB, USPTO, whipgroup

On March 8, 2017, the Patent Trial and Appeal Board (PTAB) found all claims of U.S. Patent No. 7,420,151 (“the ‘151 patent”) unpatentable following an inter partes review (IPR) trial. The ‘151 Patent is directed to short wavelength visible reflectance imaging technology and is assigned to Novadaq Technologies, Inc. (NVDQ). WHIPgroup previously conducted oral argument on behalf of its client in December 2016, contending that each claim of the ‘151 Patent was either anticipated or obvious over the prior art. In its Final Written Decision, the PTAB found WHIPgroup’s arguments persuasive and held all the claims of the patent invalid.